Press "Enter" to skip to content

Drug giant Bayer acquires RTP gene therapy startup AskBio for as much as $4B

Report: US must take concrete steps to protect status as global biotech competitivenessDrug giant Bayer is paying quite a price to acquire RTP gene therapy startup AskBio in a deal announced early today – as much as $4 billion.
Source: WRAL News

Be First to Comment

    Leave a Reply